Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia

Jacob Lønborg, Henning Kelbæk, Niels Vejlstrup, Hans Erik Bøtker, Won Yong Kim, Lene Holmvang, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Christian Juhl Terkelsen, Mikkel Malby Schoos, Lars Køber, Peter Clemmensen, Marek Treiman, Thomas Engstrøm

    186 Citationer (Scopus)

    Abstract

    Exenatide has been demonstrated to be cardioprotective as an adjunct to primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction (STEMI). The aim of the post hoc analysis study was to evaluate the effect of exenatide in relation to system delay, defined as time from first medical contact to first balloon.
    OriginalsprogEngelsk
    TidsskriftCirculation. Cardiovascular interventions
    Vol/bind5
    Udgave nummer2
    Sider (fra-til)288-95
    Antal sider8
    ISSN1941-7640
    DOI
    StatusUdgivet - 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia'. Sammen danner de et unikt fingeraftryk.

    Citationsformater